The inequitable distribution of vaccines during the COVID-19 pandemic was the final proof of the need for more home-grown ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II ...

Expects to Submit Conditional Marketing Approval Application in Europe for Iopofosine I 131 in Refractory (post-BTKi) ...

The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) from Outlook ...

Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an ...

The African Medicines Agency (AMA) will be officially launched this week in Mombasa, Kenya, at the 7th Conference of African Medicines Regulatory Authorities (SCOMRA), which gets underway Tuesday, ...

Endeavor BioMedicines ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational benefits to patients with life-threatening diseases, ...

Miguel Forte, current President of the International Society for Cell & Gene Therapy (ISCT), joins Blue Cell as a Non-Executive Director -- Highly experienced executive with deep scientific expertise, ...

Our productive engagement with the European Medicines Agency (EMA) highlighted by confirmation of eligibility to submit for a conditional ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 17 ...

Strategic Implications: Analytical findings reported today underscore ABP-450’s potential to become the first full label therapeutic biosimilar to BOTOX® in the U.S., positioning AEON to address a >$3 ...